Alpha Tau Medical(DRTS.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Alpha Tau Medical
DRTS.US
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
1.080 T
DRTS.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Alpha Tau Q1 Net Loss Expands; Plans Enrollment Completion In IMPACT Study In Q3,2026; Stock Up

    nasdaq·
    US
    DRTS
    +6.48%
    nasdaq·
    US
    DRTS
    +6.48%

    Dror Ortho-Design, Inc. 1Q 2026: Net income $(638,666), EPS $(0.00) — 10-Q Summary

    TradingView·
    US
    DRTS
    +6.48%
    US
    ARKG
    +0.04%
    US
    XBI
    -0.69%
    TradingView·
    US
    DRTS
    +6.48%
    US
    ARKG
    +0.04%
    US
    XBI
    -0.69%

    12 Health Care Stocks Moving In Monday's Intraday Session

    benzinga_article·
    US
    HRTX
    -1.31%
    US
    BMY
    +1.74%
    US
    DRTS
    +6.48%
    benzinga_article·
    US
    HRTX
    -1.31%
    US
    BMY
    +1.74%
    US
    DRTS
    +6.48%

    Alpha Tau Medical (NASDAQ:DRTS) Sets New 52-Week High - Time to Buy?

    Market Beat·
    US
    DRTS
    +6.48%
    Market Beat·
    US
    DRTS
    +6.48%

    Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT

    Tip Ranks·
    US
    DRTS
    +6.48%
    Tip Ranks·
    US
    DRTS
    +6.48%
    © 2026 Longbridge｜Disclaimer